ABT: Abbott Labs Market Cap to Revenue Ratio

Symbol and logo of brand Abbott Laboratories Inc. (ABT)

Steady growth for Abbott Laboratories (ABT) is driven by the implementation of innovative glucose monitoring systems and the expansion of its medtech portfolio. The price-to-sales ratio visualizes this trend, with the metric holding around 3.90. Revenues are based on the sale of diagnostic equipment and specialized nutrition. Operational resilience is supported by a balanced combination of in-house manufacturing plants and diversified component outsourcing.

Abbott (ABT): P/S Multiple from 07/04/2022 to 11/13/2026

Metric breakdowns and analytics for Abbott Laboratories Inc. (ABT)

- current quotes and average value forecast:
Market Price abbott.com|ABT - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Abbott Laboratories Inc.|ABT - Enterprise Value
- business book valuation details:
Net Assets per Share Abbott|ABT - Book Capitalization|Market Cap to Net Assets Ratio abbott.com|ABT - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Abbott Laboratories|ABT - Long-Term Debt to Equity|Short-Term Debt to Equity Abbott Corp.|ABT - Company Total Debt|Debt to Net Assets Ratio Abbott Laboratories Inc.|ABT - Company Long-Term Debts|Short-Term Debt Abbott|Critical Liquidity abbott.com
- net income and valuation ratios data:
ABT - Net Income|Projected Future Earnings Abbott Laboratories|ABT - P/E Multiple|Market Cap to Projected Earnings Abbott Labs|ABT - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Abbott Laboratories Inc.|ABT - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Abbott|ABT - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months abbott.com|ABT - Earnings per share growth in current year|Projected earnings per share growth rate for next year Abbott Laboratories
- issuer revenue and sales details:
ABT - Company Sales|Company Projected Revenue Volume abbott.com|ABT - P/S Multiple|Forward P/S Multiple Abbott Laboratories Inc.
Summary company analytics:abbott.com, ABT
Signature product of Abbott Corp.

By analyzing the revenue multiple dynamics of Abbott Laboratories (ABT), an investor compares the business's market value with its actual operating revenues, allowing them to filter out speculative noise from fundamental growth. The price-to-sales ratio confirms the effectiveness of medical segment diversification and management competence, determining the extent to which the asset's current price is justified by the scale of the generated cash flow.

Competing companies

TMO - Price to Sales|P/S Multiple GEHC (GE HealthCare Technologies)|MTD: Market Cap to Revenue Ratio|Waters Corp. - P/S Multiple|Price-to-Revenue Coefficient Bio-Techne Inc. TECH|BRKR: P/S Multiple|Market Cap to Revenue azenta.com|VREX (Varex Imaging Corporation) - P/S Multiple|P/S Multiple Semler Scientific Inc|Price-to-Revenue Ratio Butterfly iQ (BFLY)|Price-to-Revenue Ratio MLAB (Mesa Laboratories Corp.)|Quantum-Si - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio NNOX|Quanterix - P/S Multiple|Price to Sales 908 Devices Inc|capsovision.com (CV) - Price-to-Revenue Ratio|Price-to-Revenue Multiple MaxCyte Inc MXCT|Market Cap to Revenue RPID|P/S Multiple seer.bio|P/S Multiple HYPR|Price-to-Revenue Coefficient FONAR Corp.|Price-to-Revenue Ratio Daxor DXR|MDAI (spectral-ai.com) - Price-to-Sales Ratio|VIVS - Price-to-Revenue Ratio|aclarion.com (ACON) - Market Cap to Revenue|AKYA: P/S Multiple|Price to Sales ThermoGenesis Holdings, Inc. (THMO)|Price-to-Revenue Ratio Talis Biomedical Corp.|Market Cap to Revenue Ratio TTOO (T2 Biosystems Inc)